大系统发育簇HIV-1毒株在细胞培养中加速逃逸整合酶抑制剂
研究比较了魁北克MSM人群中大簇(20-140例)与小簇(1-4例)HIV-1分离株在体外递增浓度多替拉韦、埃替拉韦和拉米夫定压力下的逃逸速度。结果显示大簇毒株更快选择出耐药突变,多替拉韦相关突变损害复制适应性,埃替拉韦下24周内逃逸至>10 μM。
要点
- 大簇HIV-1分离株在体外对多替拉韦、埃替拉韦和拉米夫定更快选择出耐药。
- 多替拉韦下大簇毒株8-12周出现优势突变,小簇24周才出现。
- 多替拉韦相关突变降低病毒复制适应性,浓度无法升至5-10 nM以上。
核心结论
- 大系统发育簇HIV-1分离株在体外比小簇分离株更快逃逸整合酶抑制剂和拉米夫定的选择压力。
研究设计与样本
- 研究纳入大簇(20+,n=11)和小簇(1-4,n=6)的原代HIV-1分离株,在递增浓度的多替拉韦、埃替拉韦和拉米夫定中体外传代24-36周。
- 采用Sanger和深度测序评估药物选择压力下的基因型变化。
主要发现
- 多替拉韦选择下,大簇毒株8-12周内以R263K(n=7)、S153Y(n=1)或H51Y(n=1)为优势准种;小簇毒株24周后仅R263K(1/6)、S153Y(1/6)或野生型(4/6)。
- 多替拉韦相关突变损害病毒复制适应性,阻止浓度升至5-10 nM以上。
- 埃替拉韦选择下,大簇毒株8周内更早获得首个突变(T66I、A92G、N155H或S147G),24周内序贯累积多个突变导致病毒逃逸(>10 μM)。
局限性
- 需进一步研究理解大簇病毒的病毒学特征,这些特征可能有利于其传播性、复制能力和逃逸选择性抗逆转录病毒药物压力的潜力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Viral phylogenetics revealed two patterns of HIV-1 spread among MSM in Quebec. While most HIV-1 strains ( n = 2011) were associated with singleton/small clusters (cluster size 1-4), 30 viral lineages formed large networks (cluster size 20-140), contributing to 42% of diagnoses between 2011 and 2015. Herein, tissue culture selections ascertained if large cluster lineages possessed higher replicative fitness than singleton/small cluster isolates, allowing for viral escape from integrase inhibitors. METHODS: Primary HIV-1 isolates from large 20+ cluster ( n = 11) or singleton/small cluster ( n = 6) networks were passaged in vitro in escalating concentrations of dolutegravir, elvitegravir and lamivudine for 24-36 weeks. Sanger and deep sequencing assessed genotypic changes under selective drug pressure. RESULTS: Large cluster HIV-1 isolates selected for resistance to dolutegravir, elvitegravir and lamivudine faster than HIV-1 strains forming small clusters. With dolutegravir, large cluster HIV-1 variants acquired solitary R263K ( n = 7), S153Y ( n = 1) or H51Y ( n = 1) mutations as the dominant quasi-species within 8-12 weeks as compared with small cluster lineages where R263K ( n = 1/6), S153Y (1/6) or WT species (4/6) were observed after 24 weeks. Interestingly, dolutegravir-associated mutations compromised viral replicative fitness, precluding escalations in concentrations beyond 5-10 nM. With elvitegravir, large cluster variants more rapidly acquired first mutations (T66I, A92G, N155H or S147G) by week 8 followed by sequential accumulation of multiple mutations leading to viral escape (>10 μM) by week 24. CONCLUSIONS: Further studies are needed to understand virological features of large cluster viruses that may favour their transmissibility, replicative competence and potential to escape selective antiretroviral drug pressure.
引用
- Brenner BG, Ibanescu RI, Oliveira M, et al. HIV-1 strains belonging to large phylogenetic clusters show accelerated escape from integrase inhibitors in cell culture compared with viral isolates from singleton/small clusters. J Antimicrob Chemother. 2017. PMID: 28472323. doi:10.1093/jac/dkx118
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。